Clinical Trial Update: Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg [NA]

View source ↗

Summary

Adverse events observed in a bioequivalence study comparing two formulations of metformin hydrochloride 500 mg are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Biocinese | Conditions: Nutritional and Metabolic Diseases | NA | Status: UNKNOWN